INTELLIA THERAPEUTICS, INC. Diluted Shares Outstanding (Weighted Average)
INTELLIA THERAPEUTICS, INC. (NTLA) reported Diluted Shares Outstanding (Weighted Average) of 133.48 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-06
- INTELLIA THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 133.48M shares, a 28.68% increase year-over-year.
- INTELLIA THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 118.49M shares, a 14.48% increase year-over-year.
- INTELLIA THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 115.98M shares, a 13.85% increase year-over-year.
- INTELLIA THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 110.19M shares, a 9.09% increase year-over-year.
- INTELLIA THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 108.38M shares, a 9.64% increase from fiscal 2024.
- INTELLIA THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 98.85M shares, a 11.35% increase from fiscal 2023.
- INTELLIA THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 88.77M shares, a 15.33% increase from fiscal 2022.
- INTELLIA THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 76.97M shares, a 8.57% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | 133.48M shares 10-Q · filed 2026-08-06 | 126.06M shares 10-Q · filed 2026-08-06 | 122.65M shares derived: average of 3 quarters · filed 2026-08-06 | 119.53M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 118.49M shares 10-Q · filed 2026-05-11 | 117.24M shares derived: average of 2 quarters · filed 2026-05-11 | 114.89M shares derived: average of 3 quarters · filed 2026-05-11 | 112.10M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | 115.98M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 113.08M shares derived: average of 2 quarters · filed 2026-02-26 | 109.97M shares derived: average of 3 quarters · filed 2026-08-06 | 108.38M shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 110.19M shares 10-Q · filed 2025-11-06 | 106.96M shares derived: average of 2 quarters · filed 2026-08-06 | 105.84M shares 10-Q · filed 2025-11-06 | 104.82M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | 103.73M shares 10-Q · filed 2026-08-06 | 103.62M shares 10-Q · filed 2026-08-06 | 103.03M shares derived: average of 3 quarters · filed 2026-08-06 | 102.53M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | 103.50M shares 10-Q · filed 2026-05-11 | 102.69M shares derived: average of 2 quarters · filed 2026-05-11 | 102.12M shares derived: average of 3 quarters · filed 2026-05-11 | 100.84M shares derived: average of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | 101.87M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 101.44M shares derived: average of 2 quarters · filed 2026-02-26 | 99.95M shares derived: average of 3 quarters · filed 2026-02-26 | 98.85M shares 10-K · filed 2026-02-26 |
| 2024-09-30 | 101.00M shares 10-Q · filed 2025-11-06 | 98.99M shares derived: average of 2 quarters · filed 2025-11-06 | 97.84M shares 10-Q · filed 2025-11-06 | 95.99M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | 96.97M shares 10-Q · filed 2025-08-07 | 96.24M shares 10-Q · filed 2025-08-07 | 94.31M shares derived: average of 3 quarters · filed 2026-02-26 | 92.90M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | 95.50M shares 10-Q · filed 2025-05-08 | 92.98M shares derived: average of 2 quarters · filed 2026-02-26 | 91.54M shares derived: average of 3 quarters · filed 2026-02-26 | 90.70M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | 90.47M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 89.56M shares derived: average of 2 quarters · filed 2026-02-26 | 89.10M shares derived: average of 3 quarters · filed 2026-02-26 | 88.77M shares 10-K · filed 2026-02-26 |
| 2023-09-30 | 88.64M shares 10-Q · filed 2024-11-07 | 88.42M shares derived: average of 2 quarters · filed 2024-11-07 | 88.20M shares 10-Q · filed 2024-11-07 | 86.47M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | 88.19M shares 10-Q · filed 2024-08-08 | 87.98M shares 10-Q · filed 2024-08-08 | 85.74M shares derived: average of 3 quarters · filed 2025-02-27 | 83.32M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | 87.77M shares 10-Q · filed 2024-05-09 | 84.52M shares derived: average of 2 quarters · filed 2025-02-27 | 81.69M shares derived: average of 3 quarters · filed 2025-02-27 | 80.23M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | 81.26M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 78.65M shares derived: average of 2 quarters · filed 2025-02-27 | 77.71M shares derived: average of 3 quarters · filed 2025-02-27 | 76.97M shares 10-K · filed 2025-02-27 |
| 2022-09-30 | 76.05M shares 10-Q · filed 2023-11-09 | 75.94M shares derived: average of 2 quarters · filed 2023-11-09 | 75.54M shares 10-Q · filed 2023-11-09 | 75.26M shares derived: average of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | 75.82M shares 10-Q · filed 2023-08-03 | 75.28M shares 10-Q · filed 2023-08-03 | 75.00M shares derived: average of 3 quarters · filed 2024-02-22 | 74.67M shares derived: average of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | 74.75M shares 10-Q · filed 2023-05-04 | 74.58M shares derived: average of 2 quarters · filed 2024-02-22 | 74.29M shares derived: average of 3 quarters · filed 2024-02-22 | 72.76M shares derived: average of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | 74.42M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | 74.06M shares derived: average of 2 quarters · filed 2024-02-22 | 72.10M shares derived: average of 3 quarters · filed 2024-02-22 | 70.89M shares 10-K · filed 2024-02-22 |
| 2021-09-30 | 73.71M shares 10-Q · filed 2022-11-03 | 70.94M shares derived: average of 2 quarters · filed 2022-11-03 | 69.72M shares 10-Q · filed 2022-11-03 | |
| 2021-06-30 | 68.16M shares 10-Q · filed 2022-08-04 | 67.67M shares 10-Q · filed 2022-08-04 | ||
| 2020-12-31 | 55.99M shares 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |